Firstword - Executive Plus Edition?pslrid=B1FD6D8F92844EBFBE2AAF350BBCFC41 - Where people who know first, go first
    Plavix

592 documents citing Plavix

09/01/2010   Lupus study suggests blood-thinner drugs may help - (Forexpros)
 
08/30/2010   Novartis, Portola announce results of Phase II elinogrel study - (Ref. San Francisco Business Times; Bloomberg; Forexyard; London South East; Portola)
 
08/27/2010   Substudy finds AstraZeneca's Brilinta does not require genetic testing - (Ref. The Wall Street Journal; Bloomberg; Forexyard; AstraZeneca)
 
08/27/2010   AstraZeneca's Brilinta wins early backing in guidelines - (Yahoo!Health)
 
08/27/2010   Fitch affirms Bristol-Myers Squibb's 'A+' IDR; outlook negative - (MarketWatch)
 
08/25/2010   AARP report says branded drug prices increased 8.3 percent in 2009 - (Ref. The New York Times; AARP)
 
08/05/2010   NICE appraisal of clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events - (NICE)
 
07/30/2010   Sanofi CEO targeting everything but blockbusters - (Yahoo!Finance)
 
07/29/2010   Sanofi-aventis' net income jumps 61 percent in second quarter - (Ref. Forexyard; The Wall Street Journal; The New York Times; Bloomberg; Canadian Business; MarketWatch; sanofi-aventis)
 
07/26/2010   FDA staff review draws mixed views on AstraZeneca's Brilinta - (Ref. Forexpros; London South East; NASDAQ; Washington Examiner; AstraZeneca)
 
07/23/2010   Analysts speculate ahead of FDA advisory meeting on AstraZeneca's Brilinta - (Ref. The Telegraph; Bloomberg; Forexyard)
 
07/23/2010   EU panel recommends positive opinion for clopidogrel Teva Pharma - (Capital)
 
07/22/2010   Bristol-Myers Squibb's Q2 profit drops - (Ref. Bloomberg; MarketWatch; The Wall Street Journal; Washington Post; BMS)
 
07/02/2010   Sanofi-aventis looking at $20-billion acquisition in US: report - (Ref. The Wall Street Journal; Morningstar; Yahoo!Finance; Bloomberg; FinanzNachrichten; MarketWatch; TheStreet.com)
 
06/30/2010   US patent office denies Apotex request for review of Plavix patent - (Ref. The Wall Street Journal)
 
06/28/2010   Lilly’s Effient tied to higher cancer risk than Plavix in study - (Bloomberg)
 
06/28/2010   Daiichi Sankyo/Lilly respond to ACCF/AHA clinical alert on antiplatelet therapy - (Eli Lilly)
 
06/09/2010   Canada lists the top prescription drugs Americans buy online - (Los Angeles Times)
 
05/19/2010   The French Competition Authority follows up allegations of anti-competitive practices by sanofi-aventis to exclude fair generic competition for Plavix (clopidogrel) - (FinanzNachrichten)
 
05/18/2010   French antritrust body rejects sanctions on sanofi - (The Wall Street Journal)
 
05/06/2010   Acino: Good first quarter result despite clopidogrel extraordinary items - (Acino)
 
04/30/2010   Personalised genetic medicine a step closer to reality - (Bloomberg)
 
04/29/2010   Bristol-Myers Squibb's first-quarter profit rises 16 percent, cuts annual guidance - (Ref. Bloomberg; ABC News; MarketWatch; The Wall Street Journal; BMS)
 
04/29/2010   Influenza A (H1N1) vaccine sales help sanofi-aventis record increase in 1Q profit - (Ref. Bloomberg; Financial Times; Forexyard; MarketWatch; The Wall Street Journal; Yahoo!News; sanofi-aventis)
 
04/26/2010   Sanofi Q1 seen up helped by swine flu vaccines - (Forexyard)
 
04/22/2010   Health Canada approves advanced treatment for heart attack and chest pain - (Eli Lilly)
 
04/20/2010   Global prescription drug sales to reach $1.1 trillion by 2014: report - (Ref. Bloomberg; FinanzNachrichten; Yahoo!News; IMS Health)
 
04/15/2010   US court rules sanofi-aventis, Bristol-Myers Squibb can seek damages against Apotex in Plavix litigation - (Ref. Bloomberg)
 
04/13/2010   Acino warns Plavix recall to hit 2010 results - (Yahoo!Finance)
 
03/29/2010   Judge tosses antitrust suit vs. Bristol, sanofi over Plavix - (Morningstar)
 
 
 
FirstWord PLUS To add Plavix
to your ProductWatch click here


    >>
Terms of Use | Privacy Policy | All Contents Copyright © 2010 Doctor's Guide Publishing Limited. All Rights Reserved.